Skip to main content
. 2022 May 26;14(3):669–692. doi: 10.1016/j.jcmgh.2022.05.008

Table 1.

Clinical Characteristics of Patients in the PNAHS and Control Groups

Control (n = 8) PNAHS (n = 10) P-value
Gender, M/F 3/5 7/3 .074
Age, y 44.25 ± 6.494 46.45 ± 4.902 .7855
BMI, kg/m2 20.96 ± 0.7736 17.77 ± 0.8208 .0142a
TG, mmol/L 1.205 ± 0.1596 3.090 ± 0.5412 .0085b
ALB, g/L 42.18 ± 1.642 35.99 ± 1.514 .0140a
TBIL, μmol/L 13.05 ± 3.242 36.52 ± 60251 .0084b
DBIL, μmol/L 4.50 ± 2.168 16.63 ± 3.054 .0072b
IBIL, μmol/L 8.188 ± 1.978 20.75 ± 5.529 .0697
ALT, U/L 33.38 ± 12.14 80.45 ± 21.53 .1043
AST, U/L 23.29 ± 5.163 55.36 ± 11.30 .0468a
ALP, U/L 81.75 ± 25.32 187.5 ± 50.38 .1128
TCHO, mmol/L 4.309 ± 0.3181 3.990 ± 0.2924 .4728

Note: All values are presented as the mean ± standard error of the mean.

ALB, Albumin; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; DBIL, direct bilirubin; F, female; IBIL, indirect bilirubin; M, male; PNAHS, parenteral nutrition-associated hepatic steatosis; TBIL, total bilirubin; TCHO, total cholesterol; TG, triglyceride.

a

P < .05 (Student t test).

b

P < .01 (Student t test).